Summary
Lumentum Holdings Inc. reported a net loss of $31.7 million, or $0.46 per diluted share, for the fiscal second quarter ended December 31, 2022. This marks a significant decline from the net income of $56.7 million, or $0.75 per diluted share, recorded in the same period last year. The decrease in profitability was primarily driven by a substantial rise in operating expenses, including increased R&D and SG&A costs, largely due to the integration of recent acquisitions, notably NeoPhotonics. Furthermore, the company experienced a significant decrease in gross margin to 32.8% from 46.5% year-over-year, impacted by a less favorable product mix, higher amortization expenses from intangible assets, and charges related to acquiring components amid supply chain constraints. Despite the quarterly loss, Lumentum's net revenue saw a healthy increase of 13.3% to $506.0 million, driven by growth in its Optical Communications (OpComms) segment, particularly from the contribution of NeoPhotonics. The Commercial Lasers segment also contributed with a 16.0% revenue increase. However, the company's financial performance was weighed down by substantial operating expenses and a lower gross margin. Management highlighted ongoing supply chain challenges and incremental procurement costs as factors affecting profitability. Investors should monitor the company's ability to manage integration costs, improve gross margins, and navigate persistent supply chain issues in the upcoming quarters.
Key Highlights
- 1Net loss of $31.7 million in Q2 FY23, compared to a net income of $56.7 million in Q2 FY22.
- 2Diluted loss per share of $0.46, a decrease from diluted earnings per share of $0.75 in the prior year period.
- 3Net revenue increased by 13.3% to $506.0 million, driven by strong performance in the Optical Communications segment, including contributions from the NeoPhotonics acquisition.
- 4Gross margin significantly decreased to 32.8% from 46.5% year-over-year, impacted by product mix, increased amortization, and supply chain related charges.
- 5Operating expenses increased substantially, with R&D up 42.5% and SG&A up 42.6%, primarily due to increased headcount and integration costs from acquisitions.
- 6The company ended the quarter with $592.1 million in cash and cash equivalents, a decrease from $1,290.2 million at the start of the fiscal year, reflecting cash used in investing activities for acquisitions.
- 7Restructuring and related charges amounted to $13.9 million for the quarter, primarily related to integration efforts following the NeoPhotonics merger.